Literature DB >> 30915988

The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse.

Ellen M Soffin1, Bradley H Lee1, Kanupriya K Kumar1, Christopher L Wu2.   

Abstract

Reports of strategies to prevent and treat the opioid epidemic are growing. Significant attention has been paid to the benefits of opioid addiction research, clinical prescribing, and public policy initiatives in curbing the epidemic. However, the role of the anaesthesiologist in minimising opioid use and misuse remains underexplored. For many patients with an opioid use disorder, the perioperative period represents the source of initial exposure. As perioperative physicians, anaesthesiologists are in the unique position to manage pain effectively while simultaneously decreasing opioid consumption. Multiple opportunities exist for anaesthesiologists to minimise opioid exposure and prevent subsequent persistent opioid use. We present a global strategy for decreasing perioperative opioid use and misuse among surgical patients. A historical perspective of the opioid epidemic is presented, together with an analysis of opioid supply and demand forces. We then present specific temporal strategies for opioid use reduction in the perioperative period. We emphasise the importance of preoperative identification of patients at risk for long-term opioid use and misuse, review the evidence supporting the opioid sparing capacity of individual multimodal analgesic agents, and discuss the benefits of regional anaesthesia for minimising opioid consumption. We describe postoperative and post-discharge tools, including effective multimodal analgesia and the role of a transitional pain service. Finally, we offer general institutional strategies that can be led by anaesthesiologists, identify gaps in knowledge, and offer directions for future research.
Copyright © 2018 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  anaesthesia; analgesics; conduction; multimodal analgesia; narcotic; opioid-related disorders; perioperative medicine; regional anaesthesia

Mesh:

Substances:

Year:  2018        PMID: 30915988      PMCID: PMC8176648          DOI: 10.1016/j.bja.2018.11.019

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  123 in total

1.  JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations.

Authors:  D M Phillips
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

Review 2.  Perioperative ketamine for acute postoperative pain.

Authors:  R F Bell; J B Dahl; R A Moore; E Kalso
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.

Authors:  Theodore J Cicero; James A Inciardi; Alvaro Muñoz
Journal:  J Pain       Date:  2005-10       Impact factor: 5.820

4.  Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials.

Authors:  Nadia Elia; Christopher Lysakowski; Martin R Tramèr
Journal:  Anesthesiology       Date:  2005-12       Impact factor: 7.892

Review 5.  A meta-analysis of the efficacy of wound catheters for post-operative pain management.

Authors:  Anil Gupta; S Favaios; A Perniola; A Magnuson; L Berggren
Journal:  Acta Anaesthesiol Scand       Date:  2011-05-25       Impact factor: 2.105

6.  Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

Authors:  Rose A Rudd; Noah Aleshire; Jon E Zibbell; R Matthew Gladden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-01       Impact factor: 17.586

7.  Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing.

Authors:  Alexander S Chiu; Raymond A Jean; Jessica R Hoag; Mollie Freedman-Weiss; James M Healy; Kevin Y Pei
Journal:  JAMA Surg       Date:  2018-11-01       Impact factor: 14.766

8.  Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England.

Authors:  D R Long; A L Lihn; S Friedrich; F T Scheffenbichler; K C Safavi; S M Burns; J C Schneider; S D Grabitz; T T Houle; M Eikermann
Journal:  Br J Anaesth       Date:  2018-03-09       Impact factor: 9.166

9.  New Data on Opioid Use and Prescribing in the United States.

Authors:  Anne Schuchat; Debra Houry; Gery P Guy
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

Review 10.  Local anaesthetic wound infiltration for postcaesarean section analgesia: A systematic review and meta-analysis.

Authors:  Oluwaseyi Adesope; Unyime Ituk; Ashraf S Habib
Journal:  Eur J Anaesthesiol       Date:  2016-10       Impact factor: 4.330

View more
  21 in total

1.  Post-surgical pain management: time for a paradigm shift.

Authors:  Nicholas Levy; Patricia Mills; Mark Rockett
Journal:  Br J Anaesth       Date:  2019-06-12       Impact factor: 9.166

2.  Anterior cruciate ligament repair and peripheral nerve blocks: time to change our practice?

Authors:  R Ramlogan; S Tierney; C J L McCartney
Journal:  Br J Anaesth       Date:  2019-06-12       Impact factor: 9.166

3.  Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study.

Authors:  Andres Zorrilla-Vaca; Pedro T Ramirez; Maria Iniesta-Donate; Javier D Lasala; Xin Shelley Wang; Loretta A Williams; Larissa Meyer; Gabriel E Mena
Journal:  Can J Anaesth       Date:  2022-10-12       Impact factor: 6.713

4.  Neutrophil-to-Lymphocyte Ratio as an Indicator of Opioid-Induced Immunosuppression After Thoracoscopic Surgery: A Randomized Controlled Trial.

Authors:  Qi Chen; Jingqiu Liang; Ling Liang; Zhongli Liao; Bin Yang; Jun Qi
Journal:  J Pain Res       Date:  2022-06-30       Impact factor: 2.832

5.  Feasibility of Prospectively Comparing Opioid Analgesia With Opioid-Free Analgesia After Outpatient General Surgery: A Pilot Randomized Clinical Trial.

Authors:  Uyen Do; Charbel El-Kefraoui; Makena Pook; Saba Balvardi; Natasha Barone; Philip Nguyen-Powanda; Lawrence Lee; Gabriele Baldini; Liane S Feldman; Julio F Fiore; Mohsen Alhashemi; Alen Antoun; Jeffrey S Barkun; Krista M Brecht; Prosanto K Chaudhury; Dan Deckelbaum; Elise Di Lena; Sinziana Dumitra; Hiba Elhaj; Paola Fata; David Fleiszer; Gerald M Fried; Jeremy Grushka; Pepa Kaneva; Kosar Khwaja; Maxime Lapointe-Gagner; Katherine M McKendy; Ari N Meguerditchian; Sarkis H Meterissian; Haley Montgomery; Fateme Rajabiyazdi; Nadia Safa; Nawar Touma; Francine Tremblay
Journal:  JAMA Netw Open       Date:  2022-07-01

6.  Opioid-Sparing Analgesia Impacts the Perioperative Anesthetic Management in Major Abdominal Surgery.

Authors:  Miruna Jipa; Sebastian Isac; Artsiom Klimko; Mihail Simion-Cotorogea; Cristina Martac; Cristian Cobilinschi; Gabriela Droc
Journal:  Medicina (Kaunas)       Date:  2022-03-28       Impact factor: 2.948

7.  Analgesic Effect of Ropivacaine Pumped in the Sub Rectus Abdominis Muscle Sheath after Abdominoplasty.

Authors:  Sainan Wu; Richard Lung; Ningjin Wu; Ji Jin
Journal:  Aesthetic Plast Surg       Date:  2022-05-05       Impact factor: 2.708

8.  Predicting poor postoperative acute pain outcome in adults: an international, multicentre database analysis of risk factors in 50,005 patients.

Authors:  Alexander Schnabel; Maryam Yahiaoui-Doktor; Winfried Meissner; Peter Konrad Zahn; Esther Miriam Pogatzki-Zahn
Journal:  Pain Rep       Date:  2020-07-27

9.  Perioperative Opioids, the Opioid Crisis, and the Anesthesiologist.

Authors:  Daniel B Larach; Jennifer M Hah; Chad M Brummett
Journal:  Anesthesiology       Date:  2022-04-01       Impact factor: 7.892

10.  Decreased Analgesic Requirements in Super Morbidly Versus Morbidly Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy.

Authors:  Hamed Elgendy; Talha Youssef; Ahmad Banjar; Soha Elmorsy
Journal:  Obes Surg       Date:  2020-07       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.